ABOUT CELYAD ONCOLOGY
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer
At Celyad Oncology, we are pursuing next-generation cellular immunotherapies by applying our broad understanding of immunology, novel technology platforms and modular design approach to drug discovery.
Novel CAR T Immunotherapies
Advancing both allogeneic and autologous CAR T therapy candidates for the treatment of cancer
Stay informed about the latest news!
Sign up FOR our newsletter